Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
15,960,828
-
Share change
-
-1,857,586
-
Total reported value
-
$17,875,835
-
Price per share
-
$1.12
-
Number of holders
-
66
-
Value change
-
-$2,104,201
-
Number of buys
-
24
-
Number of sells
-
53
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q2 2025
As of 30 Jun 2025,
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,960,828 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Siren, L.L.C., Redmile Group, LLC, Sanofi, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and JANE STREET GROUP, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.